Patent Assignment
Reel/Frame 059874/0287
Assignment of Assignor's Interest
Recorded: 2022-05-09
Pages: 5
Assignor
E.Z. BIOXCEL SOLUTIONS PVT. LTD.
Executed: 2022-04-19
Assignee
BIOXCEL THERAPEUTICS, INC.
555 LONG WHARF DRIVE, NEW HAVEN, CONNECTICUT, 06511
Covered Property
(1)
Use of Sublingual Dexmedetomidine for the Treatment of Agitation
Related Assignments
(9)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Apr 19, 2022
From: BIOXCEL THERAPEUTICS, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 059726/0788 →
Security Interest
Apr 19, 2022
From: BIOXCEL THERAPEUTICS, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 059727/0964 →
Assignment of Assignor's Interest
Oct 28, 2022
From: BIOXCEL CORPORATION
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 061582/0841 →
Assignment of Assignor's Interest
Oct 28, 2022
From: SHARMA, SAMEER
To: E. Z. BIOXCEL SOLUTIONS PVT. LTD.
Reel/Frame 061582/0936 →
Assignment of Assignor's Interest
Oct 28, 2022
From: YOCCA, FRANK
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 061583/0089 →
Invention Assignment Agreement (Employment)
Oct 28, 2022
From: SAINI, DEEPA
To: E. Z. BIOXCEL SOLUTIONS PVT. LTD.
Reel/Frame 062350/0935 →
Invention Assignment Agreement (Employment)
Oct 28, 2022
From: NEGI, HARSH
To: E. Z. BIOXCEL SOLUTIONS PVT. LTD.
Reel/Frame 063399/0892 →
Assignment of Assignor's Interest
Oct 28, 2022
From: NANDABALAN, KRISHNAN
To: BIOXCEL CORPORATION
Reel/Frame 061582/0793 →
Security Interest
Sep 11, 2024
From: BIOXCEL THERAPEUTICS, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 068938/0906 →